BGM Group Ltd. (BGM) stock
Close on Nov 12, 2026Market cap $3.09BP/E –Yield –
BGM Group Ltd. grew revenue 51.1% to $37.92M over fiscal 2025. Free cash flow was -$3.94M, down 1395.3% from a year earlier. At the latest close the market valued the company at $3.09B.
Key statistics
Valuation at the latest close; fundamentals over fiscal 2025, balances at Sep 30, 2025
Valuation
- Market cap
- $3.09B
- P/E ratio
- –
- Price to sales
- 81.48
- Price to book
- 7.90
- Dividend yield
- –
- Free cash flow yield
- -0.13%
Fundamentals
- Revenue
- $37.92M
- Net income
- -$19.94M
- EPS, diluted
- -$0.18
- Free cash flow
- -$3.94M
Trading
- Previous close
- $8.01
- Open
- $7.70
- Day's range
- $7.70 – $7.70
- Volume
- 1,137
- Average volume (20 days)
- 11,513
- Beta (5 years)
- 0.27
- 52-week range
- $6.45 – $285.03
- RSI (14 days)
- 38.4
- Volatility (1 year)
- 123.0%
- Relative volume
- 0.16×
- WACC
- 7.4%
Market cap history
Month-end market cap since 2021, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | BGM | S&P 500 | Difference | BGM per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -24.5% | -2.7% | −21.8 pts | ||
| 3 months | -11.0% | -1.7% | −9.3 pts | ||
| Year to date | -93.0% | +11.9% | −104.9 pts | ||
| 1 year | -97.3% | +12.0% | −109.3 pts | ||
| 3 years | -88.0% | +78.2% | −166.2 pts | -50.7% | +21.2% |
| 5 years | -98.5% | +73.2% | −171.7 pts | -56.8% | +11.6% |
Nine years at a glance
Fiscal years 2017 to 2025, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases BGM filed with the SEC as exhibits to Form 8-K or 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
About BGM
Pharmaceutical Preparations
BGM Group Ltd is a holding company that conducts its business activities in China through contractual variable interest entity arrangements. The operating business primarily develops, manufactures, markets, and sells traditional Chinese medicine products and pieces, alongside operating a sausage casings business. Additionally, its enterprise network encompasses technology services, management consulting, and electronic commerce services. The group directs its offerings to consumers and commercial purchasers in the healthcare, pharmaceutical, food processing, and related commercial markets.
Company profile, executives and historyBGM stock: common questions
What is BGM's stock price?
BGM closed at $7.70 on Nov 12, 2026, down 3.87% on the day. Over the past 52 weeks it traded between $6.45 and $285.03.
What is BGM's market cap?
BGM was worth $3.09B at the close on Nov 12, 2026: the share price times the diluted shares outstanding.
What is BGM's P/E ratio?
BGM lost money over fiscal 2025 (diluted EPS -$0.18), so it has no meaningful P/E ratio.
How much revenue does BGM make?
BGM reported revenue of $37.92M for fiscal 2025, up 51.1% from a year earlier.
Does BGM pay a dividend?
No. BGM has not paid a cash dividend over the last twelve months.
How has BGM stock performed over the past year?
Including dividends, BGM returned -97.3% over the past year, against +12.0% for the S&P 500.
How many BGM shares are sold short?
0M shares were sold short at the latest FINRA report, 0.00% of the float, or 1.0 days of average trading volume.
Who are BGM's competitors?
Companies most similar to BGM by business, industry and size include BHST, JAGX, ZYBT, BON, CASIF.
See a number that looks wrong?